Aspen Pharmacare will manufacture four Aspen-branded vaccines for Africa under the agreement with the Serum Institute of India.
Bruce Whitfield talks to CEO Stephen Saad about Aspen Pharmacare's new deal and its year-end results.
An earlier agreement with Johnson & Johnson to package and sell COVID-19 vaccines under its own brand has been a disappointment due to low demand.Aspen Pharmacare Holdings says the agreement that subsidiary Aspen SA Operations concluded with the Serum Institute lasts for ten years. Aspen Pharmacare Holdings' headline earnings per share from total operations increased by 31% to 1 461,2 cents .
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Aspen seals deal with Serum Institute to make vaccines for AfricaAspen will be granted the rights to manufacture products from bulk a drug substance supplied by the world’s largest vaccine producer
Read more »
S.Africa's Aspen, India's Serum Institute sign vaccines deal for AfricaAspen Pharmacare (APNJ.J) has signed a deal with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa, as it seeks to utilise its near-idle COVID-19 vaccine production lines in South Africa.
Read more »
MARKET WRAP: Aspen bucks the trend as Cashbuild and world markets slumpStocks fall globally amid fears of a slowdown in China as Covid-19 numbers rise
Read more »
MONEY LIVE | Aspen shares rocket 6% after results | Fin24MONEY LIVE | Aspen shares rocket 6% after results.
Read more »
SA's Aspen strikes 4-vaccine deal with Indian producer after COVID vax letdownAspen Pharmacare will manufacture four Aspen-branded vaccines for Africa under the agreement with the Serum Institute of India.
Read more »